impact factor
logo
 

shopping cart

Confirmation
purchase
Item
Code
Item DescriptionPrice
CER14515Secukinumab provides sustained improvement in nail psoriasis, signs and symptoms of psoriatic arthritis and low rate of radiographic progression in patients with concomitant nail involvement: 2-year results from the Phase III FUTURE 5 study20.00 €
 Subtotal 20.00 €